UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August  14, 2018

 

PETIQ, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

(208) 939-8900

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



☒ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act (17 CFR 240.12b-2)

 

☒ Indicate by check mark if the registrant has elected not to use the extended transition period for complying with new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act (17 CFR 240.13(a)-1)

 

 

 

Item 2.02 Results of Operations and Financial Condition.*

 

On August  14, 2018,  PetIQ, Inc. (“the Company”) issued a press release announcing certain financial results for its three and six months ended June  30, 2018. A copy of the press release is attached hereto as Exhibit 99.1.

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

 

*The information furnished under Items 2.02 of this Current Report on Form 8-K, including Exhibits 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PetIQ, Inc. Reports Second Quarter 2018 Financial Results

Second Quarter Net Sales Increase 96% Year-Over-Year to $171.1 Million

Opened 20  Wellness Centers Year-to-Date

Company Raises Net Sales Outlook for Full Year 2018

EAGLE, Idaho – August  14, 2018 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and six months ended June 30, 2018.

Second Quarter 2018 Highlights Compared to Prior Year Period

Cord Christensen, PetIQ’s Chairman and Chief Executive Officer commented, “Our strong, broad-based growth continued during the second quarter resulting in record net sales.  Our team expanded PetIQ’s pet preventative and wellness veterinarian products and services offerings to further our mission to make pets’ lives better with more affordable and accessible veterinarian services and products. We are very pleased with the progress of our “Follow the Pets” growth initiatives including the opening of 17 wellness center locations in the second quarter, with all 20 VetIQ wellness centers completed.  Based on these strong operational and financial results as well as our outlook for the remainder of the year, we are raising our annual net sales guidance to $500 million. We believe our category leadership, broad product portfolio, compelling service offerings, value proposition and strong customer relationships will continue to fuel our future growth and value for our shareholders.”

 

Second Quarter 2018 Financial Results

 

Net sales increased 96% to $171.1 million for the second quarter of 2018, compared to $87.2 million for the same period in the prior year. Product segment net sales were $148.7 million and the Services segment revenues were $22.4 million in the second quarter of 2018. The increase in consolidated net sales reflects growth in existing and new retail partners, primarily within the Company’s distributed items, and the expansion of its product and services offerings.

 

Gross profit was $26.3 million, an increase of 65%, compared to $16.0 million in the same period last year. Gross margin for the quarter was 15.4%. Adjusted gross profit was $28.1 million and adjusted gross margin was 16.4% for the second quarter 2018.  The GAAP gross margin to adjusted gross margin difference of 100 basis points is a result of the exclusion of non-same-store Service segment revenue contribution of $0.8 million and related costs of sales of $1.7 million, as well as clinic launch expenses of $0.8 million.  The Company capitalized on opportunities to grow with the Company’s animal health partners and drove

incremental sales of distributed products. This resulted in a shift of our product sales mix, but had no effect on gross profit earned.

 

Net income was $5.4 million and adjusted net income was  $10.6 million for the second quarter of 2018. Adjusted net income excludes $1.1 million of operating losses associated with the non-comparable 23 newly opened veterinary wellness centers and five regional offices that have been open less than one year, $0.8 million of new wellness center launch expenses, and an additional $3.2 million of expenses that include stock-based compensation expense, tax expense, a fair value adjustment of a contingent note, integration costs, a non-recurring royalty settlement, and VIP acquisition expenses.

 

Second quarter adjusted EBITDA was $15.8 million, representing an adjusted EBITDA margin of 9.2%, compared to $7.6 million, representing 8.8%, for the same period in the prior year. 

 

Adjusted gross profit, adjusted net income, and adjusted EBITDA are non-GAAP financial measures.  Beginning second quarter 2018, the Company is providing additional non-GAAP financial measures.  The Company believes these non-GAAP financial information provides investors with additional insight into and measurement of its recent entry into the veterinary services business following the acquisition of VIP Petcare (“VIP”) in January 2018.  In the Service segment, management has begun providing a “same-store sales” to reflect revenue for veterinary clinics open for four trailing quarters.  Management believes this will provide useful information to investors as these veterinary retail service units mature and move into the comparable store base.  See “Non-GAAP Measures” for a definition of these measures and the financial tables that accompany this release for a reconciliation to the most comparable GAAP measure.

 

First Half of Fiscal 2018 Highlights Compared to Prior Year Period

Net sales increased 86% to $286.2 million for the first six months of 2018, compared to $154.2 million for the same period in the prior year. Product segment sales were $246.6 million and the Services segment net revenues were $39.6 million for the first six months of 2018.

 

Gross profit was $42.2 million, an increase of 50%, as compared to $28.2 million in the same period last year. Gross margin for the first six months of 2018 was 14.7%. Adjusted gross profit was $46.0 million and adjusted gross margin was 16.1% for the six months ended June 30, 2018.  The GAAP gross margin to adjusted gross margin difference of 140 basis points was the result of a $1.5 million purchase accounting adjustment to fair value inventory, the exclusion of a non-same-store service gross profit loss of $1.3 million and $1.2 million of clinic launch expense.

 

Net income was $1.4 million and adjusted net income was $12.0 million for the first six months of 2018. Adjusted net income excludes a $1.5 million purchase accounting adjustment to fair value inventory,  $1.1 million of operating losses associated with the Company’s non-same-store operating results from its service segment, $1.2 million of new clinic launch expenses, $3.4 million in acquisition related expenses, and an additional $3.3 million of expenses that include stock-based compensation expense, a fair value adjustment of a contingent note, integration expenses, and a non-recurring royalty settlement. 

 

For the first six months of 2018 adjusted EBITDA was $21.4 million, compared to $13.4 million for the same period in the prior year. 

 

Adjusted gross profit, adjusted net income, and adjusted EBITDA are Non-GAAP financial measures.  See “Non-GAAP Measures” for a definition of these measures and the financial tables that accompany this release for a reconciliation to the most comparable GAAP measure.

2018 Outlook

For full year 2018, the Company raised its net sales outlook and reiterated its adjusted EBITDA outlook compared to the prior year. The Company now expects the following results for the year ending December 31, 2018:  

*The Company does not provide guidance for the most directly comparable GAAP measure, net income, and similarly cannot provide a reconciliation between its forecasted adjusted EBITDA and net income metrics without unreasonable effort due to the unavailability of reliable estimates for certain items. These items are not within the Company’s control and may vary greatly between periods and could significantly impact future financial results.

Segment Review

 

Products: For the second quarter of 2018, Product segment net sales increased 71% to $148.7 million and operating income increased 64% to $16.2 million.  This compares to Product segment sales and operating income of $87.2 million and $9.9 million, respectively, for the second quarter of 2017.

 

For the six months ended June 30, 2018, the Product segment net sales increased 60% to $246.6 million and operating income increased 42% to $25.1 million.  This compares to Product segment sales and operating income of $154.2 million and $17.6 million, respectively, for the six months ended June 30, 2017. 

 

Services: For the second quarter of 2018, Service segment net revenues and operating income were $22.4 million and $2.0 million, respectively.  On a pro forma basis, Services segment revenue increased 11% from the second quarter of 2017, or approximately 7% on a same store basis.   The Company opened 17 wellness centers in the second quarter of 2018 and two additional locations in July 2018.

 

For the six months ended June 30, 2018, the Services segment net revenues and operating income were $39.6 million and $1.6 million, respectively.  This represents Services segment net revenue growth of approximately 9% on a pro forma basis over the same period ended June 30, 2017, or approximately 6% on a same store basis. 

Cash and Debt

 

The Company increased liquidity on a pro forma basis to $63 million, an increase of $51 million since March 31, 2018. This was accomplished by generating operating cash flows, paying down debt, and amending the revolving credit facility to increase availability by $25 million. 

 

As of June 30, 2018, the Company had cash and cash equivalents of $11.7 million, compared to $37.9 million at December 31, 2017.  The Company’s long-term debt balance, which is largely comprised of its revolving credit facility and term loan, was $107.4 million as of June 30, 2018, compared to $17.2 million at December 31, 2017.  The decrease in cash from December 31, 2017 is primarily due to the acquisition of VIP, which closed on January 17, 2018. The Company amended its credit agreement on August 9, 2018, to expand the capacity of the revolving line of credit from $50 million to $75 million. 

 

Conference Call and Webcast

 

The Company will host a conference call and webcast where members of the executive management team will discuss these results with additional comments and details today, August  14, 2018, at 4:30 p.m. ET. The conference call will be available live over the Internet through the “Investors” section of the Company’s

website at www.PetIQ.com.  To participate on the live call listeners in North America may dial 877-451-6152 and international listeners may dial 201-389-0879.

 

A replay of the conference call will be archived on the Company’s website and telephonic playback will be available from 7:30 p.m. ET, August 14, 2018, through September 5, 2018. North American listeners may dial 844-512-2921 and international listeners may dial 412-317-6671 the passcode is 13681893.

 

About PetIQ

 

PetIQ is a leading, rapidly growing pet health and wellness company.  Through over 40,000 points of distribution across retail and e-commerce channels, PetIQ and VIP Petcare, a wholly-owned subsidiary, have a mission to make pet lives better by educating pet parents on the importance of offering regular, convenient access and affordable choices for pet preventive and wellness veterinary products and services.  PetIQ believes that pets are an important part of the family and deserve the best products and care we can give them.  For more information, visit www.PetIQ.com.

 

Forward Looking Statements

 

This press release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could" and similar expressions.  Forward-looking statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances, or achievements expressed or implied by the forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, our ability to grow our business through acquisitions; our ability to integrate, manage and expand VIP’s business; our dependency on a limited number of customers; our ability to implement our growth strategy effectively; our ability to achieve or sustain profitability; our ability to open retail clinics and wellness centers, failure to effectively execute on our services segment rationalization plans; competition from veterinarians and others in our industry; reputational damage to our brands; economic trends and spending on pets; the effectiveness of our marketing and trade promotion programs; recalls or withdrawals of our products or product liability claims; our ability to manage our manufacturing and supply chain effectively; disruptions in our manufacturing and distribution chains; our ability to introduce new products and improve existing products; our failure to protect our intellectual property; costs associated with governmental regulation; risks related to our international operations; our ability to keep and retain key employees; and the risks set forth under the “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2017 and quarterly report on Form 10-Q for the period ended March 31, 2018.

 

Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.  The forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Consequently, you should not place undue reliance on forward-looking statements.

 

Non-GAAP Financial Measures

 

In addition to financial results reported in accordance with U.S. GAAP, PetIQ uses the following non-GAAP financial measures: Adjusted net income (loss), Adjusted gross profit,  Adjusted EBITDA, and Adjusted EBITDA Margin.

 

Adjusted net income consists of GAAP Net income (loss) adjusted for tax expense, costs to become a public company, acquisitions expenses, purchase accounting adjustments, integration costs and costs of discontinued clinics, new clinic launch expense, and stock based compensation expense.  Adjusted Net Income is utilized by management: (i) to compare operations of the Company prior to our initial public offering and (ii) to evaluate the effectiveness of our business strategies. 

 

Adjusted gross profit consists of GAAP gross profit adjusted for purchase accounting adjustments, gross profit (loss) on clinics and wellness centers that are not part of same store sales, and new clinic launch expense.  Adjusted gross profit is utilized by management to evaluate the effectiveness of our business strategies.

 

EBITDA represents net income (loss) before interest, income taxes, and depreciation and amortization. Adjusted EBITDA represents EBITDA plus management fees, stock based compensation expense, acquisition expenses, purchase accounting adjustments, fair value adjustments to contingent notes, integration costs and costs of discontinued clinics, loss on clinics and wellness centers that are not part of the same store sales, and new clinic launch expense. Adjusted EBITDA adjusts for transactions that management does not believe are representative of our core ongoing business. Adjusted EBITDA Margin is Adjusted EBITDA stated as a percentage of Net sales.  Adjusted EBITDA is utilized by management: (i) as a factor in evaluating management's performance when determining incentive compensation and (ii) to evaluate the effectiveness of our business strategies.  The Company presents EBITDA because it is a necessary component for computing Adjusted EBITDA.

 

The Company considers its same-store portfolio to consist of only those retail service regional offices and wellness centers that have been operating for four trailing quarters.  The Company believes that same-store results are useful to investors in evaluating our performance because they provide information relating to changes in operating performance without taking into account the effects of new regional offices and wellness center development.

 

We believe that the use of Adjusted Net income,  adjusted gross profit, and Adjusted EBITDA provide additional tools for investors to use in evaluating ongoing operating results and trends. In addition, you should be aware when evaluating Adjusted Net Income, adjusted gross profit,  and Adjusted EBITDA,  that in the future we may incur expenses similar to those excluded when calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by these or other unusual or non-recurring items. Our computation of Adjusted Net Income, adjusted gross profit and Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies, because all companies do not calculate Adjusted Net Income, adjusted gross profit and Adjusted EBITDA in the same manner.  Our management does not, and you should not, consider Adjusted Net Income, adjusted gross profit or Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted Net Income, adjusted gross profit and Adjusted EBITDA is that they exclude significant expenses and income that are required by GAAP to be recorded in our financial statements.  See a reconciliation of Non-GAAP measures to the most comparable GAAP measure, in the financial tables that accompany this release.

 

Definitions:

 

 

 

 

 

CONTACT:

 

 

 

PetIQ, Inc.

Condensed Consolidated Balance Sheets

(Unaudited, $’s in 000’s except for share and per share amounts)

 

PetIQ, Inc.

Condensed Consolidated Statements of Income

(Unaudited, $’s in 000’s, except for per share amounts)

 

 

 

PetIQ, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited, $’s in 000’s)

 

 

PetIQ, Inc.

Reconciliation between gross profit and adjusted gross profit

(Unaudited, $’s in 000’s)

 

 

 

 

 

 

PetIQ, Inc.

Reconciliation between Net Income and Adjusted EBITDA

(Unaudited, $’s in 000’s)

 

 

PetIQ, Inc.

Reconciliation between Net Income and Adjusted Net Income 

(Unaudited, $’s in 000’s)